Harm Reduction Therp Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HARM REDUCTION THERP, and when can generic versions of HARM REDUCTION THERP drugs launch?
HARM REDUCTION THERP has one approved drug.
There are two US patents protecting HARM REDUCTION THERP drugs.
There are forty-five patent family members on HARM REDUCTION THERP drugs in thirty-six countries and one supplementary protection certificate in one country.
Summary for Harm Reduction Therp
| International Patents: | 45 |
| US Patents: | 2 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Harm Reduction Therp
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Harm Reduction Therp | RIVIVE | naloxone hydrochloride | SPRAY, METERED;NASAL | 217722-001 | Jul 28, 2023 | OTC | Yes | Yes | 11,020,343 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Harm Reduction Therp | RIVIVE | naloxone hydrochloride | SPRAY, METERED;NASAL | 217722-001 | Jul 28, 2023 | OTC | Yes | Yes | 11,806,428 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Harm Reduction Therp Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Colombia | 6821959 | ⤷ Try a Trial |
| South Korea | 101873174 | ⤷ Try a Trial |
| New Zealand | 617442 | ⤷ Try a Trial |
| South Africa | 201308280 | ⤷ Try a Trial |
| World Intellectual Property Organization (WIPO) | 2012156317 | ⤷ Try a Trial |
| Spain | 2661838 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Harm Reduction Therp Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1685839 | 92292 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
